Title : Early decrease in α-fetoprotein, but not des-γ-carboxy prothrombin, predicts sorafenib efficacy in patients with advanced hepatocellular carcinoma.

Pub. Date : 2011

PMID : 22116493






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVES: The aim of this study was to investigate the relationships between early changes in the tumor markers alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP), and antitumor response in the early period following administration of sorafenib in patients with advanced hepatocellular carcinoma (HCC). Sorafenib angiotensin I converting enzyme Homo sapiens